Merck
MRK
#56
Rank
A$391.46 B
Marketcap
A$156.73
Share price
-0.02%
Change (1 day)
0.47%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.82

According to Merck's latest financial reports the company's current EPS (TTM) is A$11.37. In 2024 the company made an earnings per share (EPS) of A$10.12 an increase over its 2023 EPS that were of A$0.23.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$11.8216.84%
2024A$10.124308.46%
2023A$0.23-97.32%
2022A$8.5810.92%
2021A$7.7384.68%
2020A$4.19-27.2%
2019A$5.7563.44%
2018A$3.52151.11%
2017A$1.40-54.58%
2016A$3.0930.21%
2015A$2.37-61.99%
2014A$6.23180.51%
2013A$2.22-31.82%
2012A$3.266.62%
2011A$3.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.57-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$15.63 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$30.71 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.45-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.55-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$5.38-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.94-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$11.02-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
A$12.06 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.50 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA